North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Regional Analysis

6.2 North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Revenue 2019-2028 (US$ Million)

6.3 North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Forecast Analysis

7. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Analysis – by Organization Size

7.1 Small and Medium Organizations and Large Organizations

7.1.1 Overview
7.1.2 Small and Medium Organizations and Large Organizations: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Analysis – by Offerings

8.1 Products

8.1.1 Overview
8.1.2 Products: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Platforms

8.2.1 Overview
8.2.2 Platforms: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Services

8.3.1 Overview
8.3.2 Services: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Analysis – by Application

9.1 Product Design and Discovery

9.1.1 Overview
9.1.2 Product Design and Discovery: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Product Development

9.2.1 Overview
9.2.2 Product Development: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 Pre-Clinical Targeting

9.3.1 Overview
9.3.2 Pre-Clinical Targeting: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.4 Assessment of Drugs and Other Biomedical Products

9.4.1 Overview
9.4.2 Assessment of Drugs and Other Biomedical Products: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Analysis – by Clinical Indication

10.1 Cardiovascular Diseases

10.1.1 Overview
10.1.2 Cardiovascular Diseases: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.2 Neurodegenerative Diseases

10.2.1 Overview
10.2.2 Neurodegenerative Diseases: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.3 Oncology

10.3.1 Overview
10.3.2 Oncology: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.4 Rare Diseases

10.4.1 Overview
10.4.2 Rare Diseases: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.5 Metabolic Diseases

10.5.1 Overview
10.5.2 Metabolic Diseases: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.6 Immune Based Diseases

10.6.1 Overview
10.6.2 Immune Based Diseases: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.7 Infectious Diseases

10.7.1 Overview
10.7.2 Infectious Diseases: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast, 2019-2028 (US$ Million)

11. North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – North America Analysis

11.1 Overview

11.2 North America

11.2.1 North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Key Country, 2022 and 2028 (%)
11.2.1.1 North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast Analysis – by Country
11.2.1.1 US: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.1.1 US: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Organization Size
11.2.1.1.2 US: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Offerings
11.2.1.1.3 US: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Application
11.2.1.1.4 US: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Clinical Indication

11.2.1.2 Canada: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.2.1 Canada: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Organization Size
11.2.1.2.2 Canada: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Offerings
11.2.1.2.3 Canada: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Application
11.2.1.2.4 Canada: North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Clinical Indication

11.2.1.3 Mexico : North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.3.1 Mexico : North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Organization Size
11.2.1.3.2 Mexico : North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Offerings
11.2.1.3.3 Mexico : North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Application
11.2.1.3.4 Mexico : North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Breakdown, by Clinical Indication

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 InSilicoTrials Technologies

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Dassault Systèmes SE

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Certara Inc.

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Computational Life

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Ansys, Inc.

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Synopsys, Inc.

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Sensyne Health plc.

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Phesi

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Tempus

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Cerner Corporation

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

North America In-Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market